NCT00391482View on ClinicalTrials.gov

Study to Reduce Intravenous Exposures (STRIVE)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

February 28, 2005

Conditions
Hepatitis CHIV Infections
Interventions
BEHAVIORAL

Peer Mentoring Intervention for HCV-Infected IDUs

Trial Locations (3)

10029

New York Academy of Medicine, Center for Urban Epidemiologic Studies, New York

21205

Johns Hopkins University, Bloomberg School of Public Health, Baltimore

98104

Public Health Seattle & King County, Seattle

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00391482 - Study to Reduce Intravenous Exposures (STRIVE) | Biotech Hunter | Biotech Hunter